We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Insights Into Idexx (IDXX) Q2: Wall Street Projections for Key Metrics
Read MoreHide Full Article
Wall Street analysts expect Idexx Laboratories (IDXX - Free Report) to post quarterly earnings of $3.95 per share in its upcoming report, which indicates a year-over-year increase of 8.8%. Revenues are expected to be $1.2 billion, up 8.3% from the year-ago quarter.
The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.
In light of this perspective, let's dive into the average estimates of certain Idexx metrics that are commonly tracked and forecasted by Wall Street analysts.
The consensus estimate for 'Revenue- Companion Animal Group (CAG)' stands at $1.11 billion. The estimate suggests a change of +8.4% year over year.
The average prediction of analysts places 'Revenue- Other' at $4.26 million. The estimate indicates a year-over-year change of +0.2%.
According to the collective judgment of analysts, 'Revenue- Livestock and poultry diagnostics (LPD)' should come in at $33.57 million. The estimate points to a change of +5.7% from the year-ago quarter.
Analysts' assessment points toward 'Revenue- Water' reaching $54.33 million. The estimate indicates a change of +6.5% from the prior-year quarter.
Analysts expect 'Revenue- Companion Animal Group (CAG)- United States' to come in at $735.21 million. The estimate suggests a change of +7.4% year over year.
It is projected by analysts that the 'Revenue- Companion Animal Group (CAG)- International' will reach $377.49 million. The estimate suggests a change of +11.7% year over year.
Based on the collective assessment of analysts, 'Revenue- LPD- International' should arrive at $27.47 million. The estimate points to a change of +5.7% from the year-ago quarter.
Analysts forecast 'Revenue- Water- International' to reach $27.06 million. The estimate points to a change of +8.6% from the year-ago quarter.
Analysts predict that the 'Revenue- LPD- United States' will reach $6.34 million. The estimate points to a change of +9.9% from the year-ago quarter.
The collective assessment of analysts points to an estimated 'Percent of Revenue- Gross Profit - CAG' of 63.2%. The estimate is in contrast to the year-ago figure of 62.8%.
The consensus among analysts is that 'Percent of Revenue- Gross Profit - LPD' will reach 48.0%. Compared to the current estimate, the company reported 47.0% in the same quarter of the previous year.
The combined assessment of analysts suggests that 'Percent of Revenue- Gross Profit - Water' will likely reach 69.5%. The estimate compares to the year-ago value of 69.6%.
Over the past month, Idexx shares have recorded returns of +0.2% versus the Zacks S&P 500 composite's -0.5% change. Based on its Zacks Rank #3 (Hold), IDXX will likely exhibit a performance that aligns with the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
View the Zacks #1 Rank List
Image: Bigstock
Insights Into Idexx (IDXX) Q2: Wall Street Projections for Key Metrics
Wall Street analysts expect Idexx Laboratories (IDXX - Free Report) to post quarterly earnings of $3.95 per share in its upcoming report, which indicates a year-over-year increase of 8.8%. Revenues are expected to be $1.2 billion, up 8.3% from the year-ago quarter.
The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.
In light of this perspective, let's dive into the average estimates of certain Idexx metrics that are commonly tracked and forecasted by Wall Street analysts.
The consensus estimate for 'Revenue- Companion Animal Group (CAG)' stands at $1.11 billion. The estimate suggests a change of +8.4% year over year.
The average prediction of analysts places 'Revenue- Other' at $4.26 million. The estimate indicates a year-over-year change of +0.2%.
According to the collective judgment of analysts, 'Revenue- Livestock and poultry diagnostics (LPD)' should come in at $33.57 million. The estimate points to a change of +5.7% from the year-ago quarter.
Analysts' assessment points toward 'Revenue- Water' reaching $54.33 million. The estimate indicates a change of +6.5% from the prior-year quarter.
Analysts expect 'Revenue- Companion Animal Group (CAG)- United States' to come in at $735.21 million. The estimate suggests a change of +7.4% year over year.
It is projected by analysts that the 'Revenue- Companion Animal Group (CAG)- International' will reach $377.49 million. The estimate suggests a change of +11.7% year over year.
Based on the collective assessment of analysts, 'Revenue- LPD- International' should arrive at $27.47 million. The estimate points to a change of +5.7% from the year-ago quarter.
Analysts forecast 'Revenue- Water- International' to reach $27.06 million. The estimate points to a change of +8.6% from the year-ago quarter.
Analysts predict that the 'Revenue- LPD- United States' will reach $6.34 million. The estimate points to a change of +9.9% from the year-ago quarter.
The collective assessment of analysts points to an estimated 'Percent of Revenue- Gross Profit - CAG' of 63.2%. The estimate is in contrast to the year-ago figure of 62.8%.
The consensus among analysts is that 'Percent of Revenue- Gross Profit - LPD' will reach 48.0%. Compared to the current estimate, the company reported 47.0% in the same quarter of the previous year.
The combined assessment of analysts suggests that 'Percent of Revenue- Gross Profit - Water' will likely reach 69.5%. The estimate compares to the year-ago value of 69.6%.
View all Key Company Metrics for Idexx here>>>Over the past month, Idexx shares have recorded returns of +0.2% versus the Zacks S&P 500 composite's -0.5% change. Based on its Zacks Rank #3 (Hold), IDXX will likely exhibit a performance that aligns with the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .